학술논문

Multifactorial risk reduction with oral semaglutide vs comparators in the treatment of type 2 diabetes
Document Type
Journal
Source
DIABETOLOGIA; SEP 2022, 65 SUPPL 1, pS312-pS313, 2p. Supplement: 1
Subject
Language
English
ISSN
14320428